Brooks D Lindsey1, Sarah E Shelton1, F Stuart Foster2, Paul A Dayton3,4. 1. Joint Department of Biomedical Engineering, University of North Carolina-Chapel Hill and North Carolina State University, Raleigh, NC, USA. 2. Sunnybrook Health Sciences Centre, Toronto, ON, Canada. 3. Joint Department of Biomedical Engineering, University of North Carolina-Chapel Hill and North Carolina State University, Raleigh, NC, USA. padayton@email.unc.edu. 4. Biomedical Research Imaging Center, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA. padayton@email.unc.edu.
Abstract
PURPOSE: The purposes of the present study is to evaluate a new ultrasound molecular imaging approach in its ability to image a preclinical tumor model and to investigate the capacity to visualize and quantify co-registered microvascular and molecular imaging volumes. PROCEDURES: Molecular imaging using the new technique was compared with a conventional ultrasound molecular imaging technique (multi-pulse imaging) by varying the injected microbubble dose and scanning each animal using both techniques. Each of the 14 animals was randomly assigned one of three doses; bolus dose was varied, and the animals were imaged for three consecutive days so that each animal received every dose. A microvascular scan was also acquired for each animal by administering an infusion of nontargeted microbubbles. These scans were paired with co-registered molecular images (VEGFR2-targeted microbubbles), the vessels were segmented, and the spatial relationships between vessels and VEGFR2 targeting locations were analyzed. In five animals, an additional scan was performed in which the animal received a bolus of microbubbles targeted to E- and P-selectins. Vessel tortuosity as a function of distance from VEGF and selectin targeting was analyzed in these animals. RESULTS: Although resulting differences in image intensity due to varying microbubble dose were not significant between the two lowest doses, superharmonic imaging had significantly higher contrast-to-tissue ratio (CTR) than multi-pulse imaging (mean across all doses 13.98 dB for molecular acoustic angiography vs. 0.53 dB for multi-pulse imaging; p = 4.9 × 10-10). Analysis of registered microvascular and molecular imaging volumes indicated that vessel tortuosity decreases with increasing distance from both VEGFR2- and selectin-targeting sites. CONCLUSIONS: Molecular acoustic angiography (superharmonic molecular imaging) exhibited a significant increase in CTR at all doses tested due to superior rejection of tissue artifact signals. Due to the high resolution of acoustic angiography molecular imaging, it is possible to analyze spatial relationships in aligned microvascular and molecular superharmonic imaging volumes. Future studies are required to separate the effects of biomarker expression and blood flow kinetics in comparing local tortuosity differences between different endothelial markers such as VEGFR2, E-selectin, and P-selectin.
PURPOSE: The purposes of the present study is to evaluate a new ultrasound molecular imaging approach in its ability to image a preclinical tumor model and to investigate the capacity to visualize and quantify co-registered microvascular and molecular imaging volumes. PROCEDURES: Molecular imaging using the new technique was compared with a conventional ultrasound molecular imaging technique (multi-pulse imaging) by varying the injected microbubble dose and scanning each animal using both techniques. Each of the 14 animals was randomly assigned one of three doses; bolus dose was varied, and the animals were imaged for three consecutive days so that each animal received every dose. A microvascular scan was also acquired for each animal by administering an infusion of nontargeted microbubbles. These scans were paired with co-registered molecular images (VEGFR2-targeted microbubbles), the vessels were segmented, and the spatial relationships between vessels and VEGFR2 targeting locations were analyzed. In five animals, an additional scan was performed in which the animal received a bolus of microbubbles targeted to E- and P-selectins. Vessel tortuosity as a function of distance from VEGF and selectin targeting was analyzed in these animals. RESULTS: Although resulting differences in image intensity due to varying microbubble dose were not significant between the two lowest doses, superharmonic imaging had significantly higher contrast-to-tissue ratio (CTR) than multi-pulse imaging (mean across all doses 13.98 dB for molecular acoustic angiography vs. 0.53 dB for multi-pulse imaging; p = 4.9 × 10-10). Analysis of registered microvascular and molecular imaging volumes indicated that vessel tortuosity decreases with increasing distance from both VEGFR2- and selectin-targeting sites. CONCLUSIONS: Molecular acoustic angiography (superharmonic molecular imaging) exhibited a significant increase in CTR at all doses tested due to superior rejection of tissue artifact signals. Due to the high resolution of acoustic angiography molecular imaging, it is possible to analyze spatial relationships in aligned microvascular and molecular superharmonic imaging volumes. Future studies are required to separate the effects of biomarker expression and blood flow kinetics in comparing local tortuosity differences between different endothelial markers such as VEGFR2, E-selectin, and P-selectin.
Authors: Charles F Caskey; Susanne M Stieger; Shengping Qin; Paul A Dayton; Katherine W Ferrara Journal: J Acoust Soc Am Date: 2007-08 Impact factor: 1.840
Authors: K Tharp; O Israel; J Hausmann; L Bettman; W H Martin; M Daitzchman; M P Sandler; D Delbeke Journal: Eur J Nucl Med Mol Imaging Date: 2004-06-19 Impact factor: 9.236
Authors: Marzana Mantasha Mahmud; Xun Wu; Jean Lunsford Sanders; Ali Onder Biliroglu; Oluwafemi Joel Adelegan; Isabel G Newsome; Feysel Yalcin Yamaner; Paul A Dayton; Omer Oralkan Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2020-06-09 Impact factor: 2.725
Authors: Brooks D Lindsey; Jinwook Kim; Paul A Dayton; Xiaoning Jiang Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2017-05-08 Impact factor: 2.725
Authors: Brooks D Lindsey; Sarah E Shelton; K Heath Martin; Kathryn A Ozgun; Juan D Rojas; F Stuart Foster; Paul A Dayton Journal: Ann Biomed Eng Date: 2016-11-10 Impact factor: 3.934
Authors: Samantha M Fix; A Gloria Nyankima; Morgan D McSweeney; James K Tsuruta; Samuel K Lai; Paul A Dayton Journal: Ultrasound Med Biol Date: 2018-03-27 Impact factor: 2.998
Authors: Isabel G Newsome; Thomas M Kierski; Guofeng Pang; Jianhua Yin; Jing Yang; Emmanuel Cherin; F Stuart Foster; Claudia A Carnevale; Christine E M Demore; Paul A Dayton Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2021-07-26 Impact factor: 3.267
Authors: Jing Yang; Emmanuel Cherin; Jianhua Yin; Isabel G Newsome; Thomas M Kierski; Guofeng Pang; Claudia A Carnevale; Paul A Dayton; F Stuart Foster; Christine E M Demore Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2021-06-29 Impact factor: 3.267